PAIN TRIGGERS
The starting dose of 5 mg of Adderall IR is too low to produce any effect.
SaaS· pre-med studentsPain 8.00/10WTP 6.0/10Market 7.0/10Validation 9.0Confidence 92%Jul 31, 2026
StimulantTitrationLog: Structured Daily ADHD Medication & Focus Tracker
Initial psychiatric titration protocols often start at sub-therapeutic doses without clear guidance, leaving patients confused about whether medication is working or what a proper response feels like during high-stakes tasks.
adhdhealthcaremedication-trackingmobile-appproductivitystudentsworkflow
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
A patient recently diagnosed with ADHD is prescribed a starting dose of Adderall IR that is too low to produce any noticeable therapeutic effects, causing confusion about whether the medication is working or what a proper response feels like.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
Started Adderall IR 5 mg for ADHD while studying for the MCAT - no difference after 2 days. Normal?
ADHD519
Started Adderall IR 5 mg for ADHD while studying for the MCAT - no difference after 2 days. Normal?
ADHD519
Started Adderall IR 5 mg for ADHD while studying for the MCAT - no difference after 2 days. Normal?
ADHD519
im having trouble locking in
commentSo should I take 2 of the 5 mg pills like i dont wanna take too much dosing as im terrified. Been working in the ED and im seeing some terrifying drug OD’s so its scary. Ik its a controller substance but i dont want to start the new med(Qelbree) and would prefer just to stick the aderall. I also have some type of white coat HTN probably from anxiety. Idk what i should do, my mcat is sept 11 and im having trouble locking in
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
pre-med studentsNewly Diagnosed A D H D Students And Professionals
High-achieving adults undergoing initial medication titration who struggle to objectively evaluate therapeutic efficacy versus sub-therapeutic doses.
Context
Determine if a low initial dose of ADHD medication is normal while managing high-stakes exam preparation (MCAT).
Reaching out to online communities to gauge normal medication responses and dosing experiences.
Calling the psychiatrist's office early to report lack of efficacy or discuss alternative adjunctive medications.
Current Workarounds
reaching out to online communities to gauge normal medication responses and dosing experiences
calling the psychiatrist's office early to report lack of efficacy or discuss alternative dosing
relying on subjective, unlogged memory when speaking with prescribers
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Initial psychiatric titration protocols often start at sub-therapeutic doses without clear guidance on what patients should realistically expect day-to-day.
Short-acting medication instructions (once daily vs twice daily) can fail to cover the expected duration needed for targeted high-focus tasks like long exams.
OPPORTUNITY & VALUE
Why Now
Multiple commenters state that starting doses like 5mg feel excessively low, creating confusion about efficacy versus expected sensations during high-focus tasks.
Value Proposition
Purpose-built specifically for the chaotic initial titration window rather than long-term general habit or symptom tracking.
Product Direction
A mobile and web companion app designed specifically for medication titration periods that tracks daily dose timing, symptom coverage, adverse effects, and structured focus metrics to share cleanly with psychiatrists.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$9/moIndividual monthly subscription · cancel anytime
Model
SaaS subscription
WILLINGNESS TO PAY
Users facing high-stakes exams like the MCAT experience acute operational pain and anxiety during titration failures, making a low-cost clarity tool a high-ROI purchase for peace of mind.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Track titration clarity and optimize prescriber check-ins in 30 days.”
A mobile and web companion app designed specifically for medication titration periods that tracks daily dose timing, symptom coverage, adverse effects, and structured focus metrics to share cleanly with psychiatrists.
Core Features
Daily structured check-in logging dose, timing, and focus duration
Symptom-vs-expectation education prompts for titration phases
Exportable summary report formatted for psychiatric follow-up visits
Weekly Roadmap
1
W1-W2
Core logging flow built for daily dose tracking and focus scoring.
- •Design minimalist mobile-friendly web logging UI
- •Implement database schema for daily doses and symptom metrics
- •Build streak and reminder notification logic
2
W3-W4
Doctor summary report generator and educational prompts completed.
- •Build PDF export feature aggregating titration history
- •Draft evidence-based titration expectation micro-content
- •Integrate user feedback loops
3
W5
Billing integration and private beta launch with 10 users.
- •Integrate Stripe subscription checkout
- •Onboard beta users from pre-med and ADHD communities
- •Refine logging friction points based on user telemetry
4
W6
Public launch in target communities with first active signups.
- •Publish launch post on r/ADHD and related spaces
- •Monitor conversion rates and onboarding drop-offs
- •Establish customer support feedback channel
Launch Strategy
Target ADHD support communities and academic subreddits (r/ADHD, r/Mcat, r/adhdwomen)
RISKS & ASSUMPTIONS
Top Risks
Medical advice liability boundaries
The app must strictly avoid interpreting doses or giving medical advice, ensuring it functions purely as an observation and reporting tool.
Short user lifecycle
Titration is a temporary phase, meaning users may churn quickly once a stable dose is established.
Adherence to daily logging during executive dysfunction
Target users struggling with ADHD symptoms may find daily consistent data entry challenging without frictionless UI.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 4 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "healthcare", "medication-tracking", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "StimulantTitrationLog: Structured Daily ADHD Medication & Focus Tracker" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.